What is he best known for?
The fields of study he is best known for:
- Cancer
- Gene
- Internal medicine
Samuel Singer focuses on Cancer research, Sarcoma, Pathology, Internal medicine and Gastrointestinal stromal tumors.
His Cancer research research is multidisciplinary, incorporating perspectives in Mutation, Cancer and Receptor tyrosine kinase.
His Sarcoma research is multidisciplinary, relying on both Survival analysis and Soft tissue.
His Internal medicine research integrates issues from Endocrinology and Oncology.
His research in Oncology intersects with topics in Sunitinib malate, Tolerability and Surgery.
His work focuses on many connections between Gastrointestinal stromal tumors and other disciplines, such as Tyrosine phosphorylation, that overlap with his field of interest in Carcinogenesis.
His most cited work include:
- Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. (3544 citations)
- The landscape of somatic copy-number alteration across human cancers (2544 citations)
- Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor (1920 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Cancer research, Sarcoma, Internal medicine, Surgery and Pathology.
His Cancer research research includes elements of Mutation, Gene and Receptor tyrosine kinase.
Samuel Singer has researched Sarcoma in several fields, including Survival analysis, Metastasis and Radiation therapy.
His Internal medicine study combines topics in areas such as Gastroenterology, Endocrinology and Oncology.
Samuel Singer has included themes like Fusion gene and Fluorescence in situ hybridization in his Pathology study.
His GiST research is multidisciplinary, incorporating elements of Tyrosine kinase, Stromal tumor and Imatinib mesylate.
He most often published in these fields:
- Cancer research (33.53%)
- Sarcoma (29.61%)
- Internal medicine (29.00%)
What were the highlights of his more recent work (between 2015-2021)?
- Cancer research (33.53%)
- Internal medicine (29.00%)
- Oncology (18.13%)
In recent papers he was focusing on the following fields of study:
Cancer research, Internal medicine, Oncology, Sarcoma and Gene are his primary areas of study.
His studies in Cancer research integrate themes in fields like Undifferentiated Pleomorphic Sarcoma, Downregulation and upregulation, microRNA, Myxofibrosarcoma and Regulation of gene expression.
In general Internal medicine study, his work on GiST, Combination therapy and Progression-free survival often relates to the realm of In patient, thereby connecting several areas of interest.
His Oncology research also works with subjects such as
- Clinical endpoint which is related to area like Phases of clinical research,
- Surgery most often made with reference to Clinical trial,
- Stromal tumor that connect with fields like Tolerability,
- Survival rate and related Nomogram.
His work in Sarcoma tackles topics such as Fusion gene which are related to areas like Gene rearrangement and Soft tissue.
His biological study spans a wide range of topics, including Cancer and PTEN.
Between 2015 and 2021, his most popular works were:
- Pan-cancer analysis of whole genomes (538 citations)
- Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas (327 citations)
- Genomic and Functional Approaches to Understanding Cancer Aneuploidy (296 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
Samuel Singer mainly investigates Cancer research, Sarcoma, Internal medicine, Oncology and Surgery.
He interconnects DNA methylation, Chromatin, microRNA, Signal transduction and Regulation of gene expression in the investigation of issues within Cancer research.
Sarcoma is a subfield of Pathology that Samuel Singer investigates.
When carried out as part of a general Pathology research project, his work on Soft tissue is frequently linked to work in CD99, therefore connecting diverse disciplines of study.
In the subject of general Surgery, his work in Prospective cohort study is often linked to Solitary fibrous tumor, thereby combining diverse domains of study.
His Fusion gene research includes elements of Mutation and Immunohistochemistry.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
